
Dr. Zerwas, an anesthesiologist from Richmond, served in the Texas House of Representatives from 2007 to 2019. He stepped down in September to become The University of Texas System’s new executive vice chancellor for health affairs.
“A physician, an advocate, and a citizen-legislator, Dr. Zerwas has served the citizens and patients of Texas with distinction,” AMA Board Chair Jesse M. Ehrenfeld, MD, said in a statement. “As a legislator, he stood on principle, and put science and evidence first when fighting for public health, his constituents, and the people of Texas. For his outstanding work and leadership, the AMA is pleased to present Dr. John M. Zerwas with the Nathan Davis Award.”

Workers' compensation system and individual insurance carrier scorecards with year-to-date performance information can now be viewed online. The scorecards provide summary information related to complaints, timely reporting and payment of initial temporary income benefits, and timely reporting of medical bills and reconsideration medical bills.
The scorecard is on the TDI website.

Substance use is a complex problem with devastating and lasting effects across the lifespan. It strains our families, it ravages our communities, and threatens the well-being of our entire state. While opioids are still cause for concern, recent trends on the use of methamphetamines, marijuana, other illicit drugs, and alcohol cannot be ignored.
As the state agency entrusted with improving the health, safety, and well-being of Texas, DSHS is committed to addressing substance use.

The Health Resources and Services Administration (HRSA) is accepting applications for the fiscal year 2020 Addiction Medicine Fellowship (AMF) Program. The application cycle closes on February 25, 2020.
Please note that modifications have been made to the original Notice of Funding Opportunity. Download the latest version before applying.

|
|
Texas Pain Society Emeritus Board Member, C.M. Schade, MD, PhD, PE Elected Presiding Officer of the Prescription Monitoring Program Advisory Committee. January 15, 2020 |
Below is an excerpt from an article published on January 15, 2020 in the Texas Society of Anesthesiologist Newsletter:

On the Shoulders of Giants: Legends of Texas Anesthesiology Gabor B. Racz, M.D., ChB, DABPM, FIPP
Grover E. Murray Professor

|
|

|
Open Payments: Review and Dispute Data by December 31 On June 28, CMS published program year 2018 Open Payments data along with updated and newly submitted data from previous program years (2013-2017). This data is available for review and dispute through December 31. Physicians and teaching hospitals: Review of the data is voluntary but strongly encouraged. Use the Open Payments Search Tool to review publicly available data. If you believe any records attributed to you are inaccurate, you may initiate a dispute and work with the reporting entity to reach a resolution. Note: CMS does not mediate disputes. |
Texas Medical Board Press Release
FOR IMMEDIATE RELEASE
November 27, 2019

Researchers at Johns Hopkins Hospital reported that patients treated with buprenorphine for opioid use disorder show surprisingly significant improvements in adhering to medications for other chronic unrelated conditions.
Published in the journal Medical Care (2019;57[9]:667-672), the population-based, retrospective study reviewed medical records for more than 12,000 patients with a diagnosis of opioid use disorder (OUD) who were given buprenorphine, a partial opioid agonist widely used to treat OUD. Expanded use of buprenorphine is linked with the national epidemic of opioid misuse. In 2016, approximately 700,000 Americans filled buprenorphine prescriptions—more than double the number 10 years earlier. However, a recent study found disparities in access to the medication. The rate of Medicaid-covered prescriptions for buprenorphine was much lower in states that did not expand their Medicaid programs in accordance with the Affordable Care Act.
Novitasphere, our free, secure internet portal, now provides users with access to Financial Information to obtain the following:
In addition, users are able search using the Financial Control Number lookup tool to identify the claim involved.
Important reminder! Effective January 1, 2020, all claims submitted to Medicare must be billed with the Medicare Beneficiary Identifier (MBI) in place of the Health Insurance Claim number (HICN). Use the MBI Lookup tool in Novitasphere to obtain your patients’ MBIs! Angela from Professional Rehab Associates finds the MBI Lookup tool to be one of the most beneficial features in Novitasphere. “I love that when patients give us their old Medicare cards, I can still look it up to get their new ID number.”

DETROIT — The U.S. Drug Enforcement Administration is warning the public about a counterfeit medication that is killing people.
The DEA says drug cartels of manufacturing mass quantities of counterfeit pills containing fentanyl, a dangerous synthetic opioid that is lethal in some doses.
A DEA statement says the cartels are capitalizing on the opioid epidemic and the counterfeit pills are responsible for thousands of opioid-related deaths in America each year.

The Trump administration has launched a smart new salvo in the public health offensive against the opioid epidemic.
Addiction to these prescription painkillers and related street drugs continues to wreak havoc in communities across the nation. Last week, the White House announced the launch of a new website that will make it easier to find specialized medical care close to home.
This confidential, easy-to-use resource has a name succinctly summing up its mission — FindTreatment.gov. It also allows individuals to customize their search results beyond location, a feature that existing “find a substance abuse provider” websites often don’t offer.

Input Needed for 2020 Medical Quality Review Annual Audit Plan
The Division of Workers’ Compensation is asking for input on the 2020 Medical Quality Review Annual Audit Plan (Annual Plan). The Annual Plan sets the priorities for the Medical Quality Review Panel audits during the upcoming year.
More information is on the TDI website.


The National Prescription Drug Take Back Day aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse of medications.
Search by zip code or city/state to find a collection site near you.


The Research and Evaluation Group has released a report on Texas pharmacy closed formulary outcomes. This study looks at injured employee outcomes such as return-to-work rates and health outcomes since the formulary was implemented.
Need just the key findings? Check the TDI website for our new snapshot tool on the pharmacy formulary report.


**Review and Dispute activities start on April 1st and can continue until end of the calendar year**